TrialAllergy2021

Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.

Isao Ohsawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.